These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12896954)
21. Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. Möller HJ; Steinmeyer EM Eur Neuropsychopharmacol; 1994 Mar; 4(1):55-9. PubMed ID: 8204997 [TBL] [Abstract][Full Text] [Related]
22. Finding the right antidepressant medication. Johns Hopkins Med Lett Health After 50; 2000 Oct; 12(8):6-7. PubMed ID: 11002753 [No Abstract] [Full Text] [Related]
23. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline]. MMW Fortschr Med; 2004 Jul; 146(27-28):56. PubMed ID: 15526675 [No Abstract] [Full Text] [Related]
25. A double-blind, multicentre study of paroxetine and mianserin in depression. Mertens C; Pintens H Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770 [No Abstract] [Full Text] [Related]
26. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243 [TBL] [Abstract][Full Text] [Related]
29. Are SSRIs true antidepressant drugs? A plea for the re-evaluation of their therapeutic potential and safety. Loonen AJ Pharm World Sci; 1997 Apr; 19(2):70-2. PubMed ID: 9151344 [No Abstract] [Full Text] [Related]
30. Paroxetine in major depression. Jureidini J; Tonkin A J Am Acad Child Adolesc Psychiatry; 2003 May; 42(5):514; author reply 514-5. PubMed ID: 12707552 [No Abstract] [Full Text] [Related]
31. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Dechant KL; Clissold SP Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852 [TBL] [Abstract][Full Text] [Related]
32. Synergistic benefits of serotonin and noradrenaline reuptake inhibition. Nelson JC Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344 [No Abstract] [Full Text] [Related]
35. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline. Kuhs H; Schlake HP; Rolf LH; Rudolf GA Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961 [TBL] [Abstract][Full Text] [Related]
36. [Mirtazapine versus other antidepressive agents for depression]. Knud Larsen J Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468 [TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors: THREAD trial may show way forward. Peveler R; Kendrick T; BMJ; 2005 Feb; 330(7488):420-1. PubMed ID: 15718552 [No Abstract] [Full Text] [Related]
38. Concerns regarding antidepressant drug use during pregnancy. Urato AC J Psychiatry Neurosci; 2006 Nov; 31(6):411; author reply 411-2. PubMed ID: 17136220 [No Abstract] [Full Text] [Related]
39. Antidepressants and the risk of suicidal behaviors. Jick H; Kaye JA; Jick SS JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848 [TBL] [Abstract][Full Text] [Related]